Teslas Full SelfDriving Supervised Debuts in China Amid Intensifying Competition from Local EV Rivals OpenAI Takes Early Lead in AI IPO Race FirstMover Advantage Could Shape Market Nvidias Earnings Reveal 200 Billion Opportunity in Edge Computing Despite China Concession Tesla Launches Full SelfDriving Supervised in China Entering Competitive Market After Lengthy Delay Alibaba Unveils Enhanced Zhenwu AI Chip and New Large Language Model NASA Taps Blue Origin for First of Three Uncrewed Lunar Missions as 20 Billion Moon Base Plans Take Shape POWL Q1 2026 Earnings EPS Misses Estimates by Nearly 10 BELFA Q1 2026 Earnings EPS Surpasses Estimates as Stock Jumps 688 CRDL Q4 2025 Earnings Narrower Loss Surpasses Estimates Amid Clinical Progress AZZ Inc AZZ Q1 2026 Earnings EPS Beat Amid Solid Execution Revenue Details Not Disclosed LCID Q1 2026 Earnings WiderThanExpected Loss Highlights Persistent Cash Burn OneStream Inc OS Q4 2025 Earnings Strong EPS Beat Drives Investor Optimism Heartland Express HTLD Gains 218 as Shares Test Key Resistance Zone Globavend Holdings GVH Surges Over 6 Key Levels and Volume Dynamics Terra Innovatum Global NKLR Edges Higher Amid Steady Trading Bragg Gaming Group BRAG Navigates Near Support as Bearish Pressure Persists Saba Capital Income Opportunities Fund II SABA Holds Steady Near Support Amid Low Volatility Home Sellers Question Commission Rates After NAR Ruling Will a 1 Million Listing Cost Less Than 6 PLX Q1 2026 Earnings Substantial EPS Surprise Drives Stock Rally Colony Bankcorp CBAN Holds Near Resistance as Volume Fades Interlink Electronics Q3 2025 Earnings Narrowed Loss Beats Expectations Amid Opaque Revenue Picture SES AI Q1 2026 Earnings EPS Misses Estimates Stock Rises Despite WiderThanExpected Loss Akebia Therapeutics AKBA Q1 2026 Earnings EPS Misses Estimates Amidst Flat Stock Reaction LBRDK Q3 2025 Earnings EPS Surges Past Estimates Stock Reacts Modestly NTAP Q1 2026 Earnings Slight EPS Beat Drives Positive Stock Reaction CBIO Q1 2026 Earnings Narrowed Loss Beats Expectations as Cash Management Remains Focus Kura Oncology Q1 2026 Earnings Wider Loss as Clinical Progress Continues